DKFZ MRinRT 2021 – Virtual

18-21 April 2021


The development of a fully adaptive, AI-powered treatment planning software is urgently needed. We are proud to be introducing our new era of MR-based proudcts that will pave the way towards this vision of radiation therapy on the fly for more efficient, safe and precise treatment for cancer patients.

Professor Nikos Paragyios
CEO & CTO at TheraPanaceaProfessor of Mathematics – University of Paris-Saclay
Editor in Chief, Computer Vision at Elsevier


AI: the missing link in MR-guided radiotherapy?

TheraPanacea is thrilled to engage a fascinating conversation with experts in Medical Physics, Radio-oncology and AI, come & listen to their insights.

Prof. Daniela Thorwarth

University Hospital Tübingen,

Prof. Enis Özyar

Acibadem MAA University, Maslak Hospital,

Prof. Nikos Paragyios

Founder & CEO

Thais ROQUE, PhD

Research & Clinical Partnerships Manager

What do KOLs think of ART-Plan™?

ART-Plan™ has experienced a very high level of acceptance in the different teams of our department in the University Hospital for Radiation Oncology Tübingen, Germany, as it saves a lot of valuable time that can be used for complex treatment planning tasks and interdisciplinary discussions.

Professor Daniela Thorwarth
Head of Biomedical Physics Research University of Tübingen,


Get smarter – AI in Radiation Oncology

Andreas Schulte

Director International Business Development,

Watch Replay